Results 41 to 50 of about 2,230,889 (288)

Reversal of hepatorenal syndrome type 1 with terlipressin plus albumin vs. placebo plus albumin in a pooled analysis of the OT-0401 and REVERSE randomised clinical studies [PDF]

open access: yes, 2017
Background The goal of hepatorenal syndrome type 1 (HRS-1) treatment is to improve renal function. Terlipressin, a synthetic vasopressin analogue, is a systemic vasoconstrictor used for the treatment of HRS-1, where it is available.
Araya, V.   +11 more
core   +2 more sources

RETRACTED ARTICLE: Candesartan Protects Against Cadmium-Induced Hepatorenal Syndrome by Affecting Nrf2, NF-κB, Bax/Bcl-2/Cyt-C, and Ang II/Ang 1–7 Signals

open access: yesBiological Trace Element Research, 2022
Cadmium (Cd) is a serious pollutant in the environment. Candesartan is an angiotensin II (Ang II) receptor antagonist with promising diverse health benefits.
E. Kamel   +5 more
semanticscholar   +1 more source

The hepatorenal syndrome

open access: yesGastroenterology, 1979
The patient was a 45-yr-old alcoholic white male admitted to the Albany Medical Center Hospital (AMCH) because of increasing jaundice, dark urine, light stools, and ascites of 4 mo duration. He had been a heavy drinker for the past 15 yr. One year before admission he noted easy bruising, epistaxis, and intermittent vague abdominal discomfort.
Robert V. Milora   +4 more
openaire   +3 more sources

CAQ Corner: Basic concepts of transplant immunology

open access: yes, 2022
Liver Transplantation, EarlyView.
Amanda Cheung, Josh Levitsky
wiley   +1 more source

Population Based Trends in the Incidence of Hospital Admission for the Diagnosis of Hepatorenal Syndrome: 1998–2011

open access: yesInternational Journal of Nephrology, 2016
Background and Objectives. Hepatorenal syndrome carries a high risk of mortality. Understanding the incidence and mortality trends in hepatorenal syndrome will help inform future studies regarding the safety and efficacy of potential therapeutic ...
Manish Suneja   +4 more
doaj   +1 more source

HEPATORENAL SYNDROME WITH ACUTE RENAL FAILURE IN PATIENTS WITH CHRONIC LIVER DISEASE: MODERN ASPECTS OF CLINICAL PRESENTATION AND INTENSIVE CARE

open access: yesКреативная хирургия и онкология, 2018
Introduction. Acute renal failure is considered a functional, progressive, oliguric, but reversible kidney disease that occurs due to severe liver disease with hepatic insufficiency.
R. R. Nagimullin   +2 more
doaj   +1 more source

TIPS for the treatment of refractory ascites, hepatorenal syndrome and hepatic hydrothorax: a critical update [PDF]

open access: yes, 2010
Refractory ascites is a frequent complication of advanced cirrhosis and is associated with hepatorenal syndrome and hepatic hydrothorax. Large volume paracentesis and pleurodesis are regarded as first-line treatments in patients who do not respond ...
Gerbes, Alexander L., Roessle, Martin
core   +1 more source

The Current Management of Hepatorenal Syndrome–Acute Kidney Injury in the United States and the Potential of Terlipressin

open access: yesLiver transplantation, 2021
Acute kidney injury (AKI) in the setting of cirrhosis (hepatorenal syndrome [HRS]–AKI) is a severe and often fatal complication of end‐stage liver disease.
S. Flamm   +8 more
semanticscholar   +1 more source

Acute kidney injury and hepatorenal syndrome in cirrhosis

open access: yesWorld Journal of Gastroenterology, 2021
Acute kidney injury (AKI) in cirrhosis, including hepatorenal syndrome (HRS), is a common and serious complication in cirrhotic patients, leading to significant morbidity and mortality. AKI is separated into two categories, non-HRS AKI and HRS-AKI.
Kapil Gupta   +9 more
semanticscholar   +1 more source

Acute Kidney Injury in Liver Cirrhosis

open access: yesDiagnostics, 2023
Acute kidney injury (AKI) is common in cirrhotic patients affecting almost 20% of these patients. While multiple etiologies can lead to AKI, pre-renal azotemia seems to be the most common cause of AKI.
Rose Mary Attieh, Hani M. Wadei
doaj   +1 more source

Home - About - Disclaimer - Privacy